Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05919693
Status:
COMPLETED
Last Update Posted:
2023-12-07
First Post:
2023-06-14
Brief Title:
A 2-part Study Consisting of Multiple Ascending Dose MAD Safety Study and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal IVT EYE103 in Patients With Diabetic Macular Edema DME or Neovascular Age-related Macular Degeneration NVAMD
Sponsor:
Organization:
EyeBiotech Ltd
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
92
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: